Long-term lamivudine for chronic hepatitis B and cirrhosis: A real-life cohort study
Author(s) -
Minghua Su
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i46.13087
Subject(s) - medicine , lamivudine , gastroenterology , cumulative incidence , cirrhosis , hepatocellular carcinoma , alanine transaminase , hepatitis b , regimen , prospective cohort study , hepatitis b virus , cohort , surgery , immunology , virus
To investigate clinical outcomes of chronic hepatitis B (CHB) and liver cirrhosis (LC) patients under whole-course management with lamivudine (LAM).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom